Article Text

other Versions

CSF study in paraneoplastic syndromes
  1. Dimitri Psimaras (dimitri.psimaras{at}
  1. Salpetrière Hospital, France
    1. Antoine F Carpentier (antoine.carpentier{at}
    1. Avicenne Hospital, France
      1. Carlotta Rossi (rossi{at}
      1. Laboratory of Clinical Epidemiology, Villa Camozzi, Bergamo, Italy


        Objective: Paraneoplastic neurological syndromes (PNS) probably result from an immune reaction against antigens shared by the nervous system and tumour cells. To characterize CSF alterations in these syndromes, we studied a large series of paraneoplastic patients.

        Methods: Using the PNS European database which includes patients diagnosed with PNS in Europe, we reviewed the clinical data of all patients included between 2000 and 2007 for which information on the CSF was available. Patients were studied if they met the following inclusions criteria: a) definite paraneoplastic disease with anti-Hu, anti-Yo, anti-CV2, anti-Ri anti-Ma/Ta and anti-Tr antibodies; b) clinical information available; c) at least 1 CSF study.

        Results: 295 patients met the inclusion criteria. Abnormal CSF (pleiocytosis and/or high protein level and/or oligoclonal bands) was found in 93% of the patients. Pleiocytosis, but not hyperproteinorachia, was more frequently seen in patients in whom the CSF study was done early in the evolution. In 24 patients, OCB were the only abnormality found in the CSF (10%). Elevated numbers of cells were found in 47% of the patients before the 3rd month, vs 28% after the 3rd month (p<0.01). This evolution might suggest a sub-acute inflammation phase within the nervous system, followed by a non-inflammatory phase. The inflammation profile was similar in all antibody types, cancers or neurological syndromes of the PNS. Surprisingly, anti-Hu patients with high pleiocytosis at time of diagnostic had a better survival in this study than those without pleiocytosis, (572 days vs 365 days, p=0.05).

        Conclusion: CSF inflammation is a common finding in PNS patient and can be a helpful tool for the diagnosis, especially if this analysis is done within 3 months after neurological onset.

        Statistics from

        Request permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        Linked Articles